East Carolina University

Futó vizsgálatok

• Toboroz

  The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

  NCT07560826· 2. fázis· Wake Forest University Health Sciences· Forrás

• Toboroz

  Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  NCT07195591· 3. fázis· GT Medical Technologies, Inc.· Forrás

• Toboroz

  A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  NCT06890338· 2. fázis· AbbVie· Forrás

• Toboroz

  Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

  NCT07173205· East Carolina University· Forrás

• Toboroz

  Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

  NCT07007962· 3. fázis· Sanofi· Forrás

• Toboroz

  Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

  NCT07095127· 2. fázis· Nuvig Therapeutics, Inc.· Forrás

• Toboroz

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  NCT07190222· 3. fázis· Sanofi· Forrás

• Toboroz

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· 3. fázis· Takeda· Forrás

• Toboroz

  A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  NCT07059000· 3. fázis· Kedrion S.p.A.· Forrás

• Toboroz

  Remote Ischemic Conditioning and Spinal Reflex Modulation in Children With Cerebral Palsy

  NCT07390760· East Carolina University· Forrás

• Toboroz

  Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  NCT06824168· 2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· 2. fázis· CSL Behring· Forrás

• Toboroz

  Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  NCT06577441· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  NCT06317662· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  NCT06672146· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  NCT06401330· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· 3. fázis· Takeda· Forrás

• Toboroz

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  NCT06717347· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT06588478· 2. fázis· Loxo Oncology, Inc.· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  NCT06439082· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  NCT06561386· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  NCT06317649· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  NCT05554406· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  NCT05554393· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  NCT06546670· 1/2. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT06508658· 3. fázis· Genmab· Forrás

• Toboroz

  Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

  NCT06205485· 3. fázis· Canadian Cancer Trials Group· Forrás

• Toboroz

  A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

  NCT06064097· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Physical Activity to Mitigate PreEclampsia Risk

  NCT06319014· East Carolina University· Forrás

• Toboroz

  MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  NCT05564390· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

  NCT06226571· 1. fázis· Syndax Pharmaceuticals· Forrás

• Toboroz

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· 2/3. fázis· CSL Behring· Forrás

• Meghívásos bevonás

  A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF

  NCT06335082· Heart Rhythm Clinical and Research Solutions, LLC· Forrás

• Toboroz

  Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  NCT06172296· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

  NCT05966194· 2. fázis· EpicentRx, Inc.· Forrás

• Toboroz

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  NCT05939414· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  NCT06149286· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  NCT06091865· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· 3. fázis· United Therapeutics· Forrás

• Toboroz

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  NCT05673148· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

  NCT05812807· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  NCT05675410· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  NCT04124120· Weill Medical College of Cornell University· Forrás

• Toboroz

  Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

  NCT06071377· National Alliance for Sickle Cell Centers· Forrás

• Toboroz

  A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  NCT05382338· 3. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT05578976· 3. fázis· Genmab· Forrás

• Toboroz

  mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  NCT05677490· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

Showing 50 of 150.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok21 toboroz
• Akut mieloid leukémia (AML)10 toboroz
• Akut limfoid leukémia (ALL)7 toboroz
• Immune thrombocytopenia (ITP)5 toboroz
• Mielodiszplasztikus szindróma (MDS)5 toboroz
• Petefészekrák5 toboroz
• Krónikus limfoid leukémia (CLL)4 toboroz
• Mieloproliferatív neopláziák4 toboroz
• Sarlósejtes vérszegénység4 toboroz
• Vastagbélrák4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)3 toboroz
• Mielóma multiplex3 toboroz
• Szarkóma3 toboroz
• Tüdőrák3 toboroz
• Vesedaganat3 toboroz
• Down syndrome2 toboroz
• Elhízás2 toboroz
• Follikuláris limfóma2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hasnyálmirigyrák2 toboroz
• Idiopátiás tüdőfibrózis2 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Melanóma2 toboroz
• Neuroblasztóma2 toboroz
• Pitvarfibrilláció2 toboroz
• Prosztatarák2 toboroz
• Amiloidózis1 toboroz
• Áttétes emlőrák1 toboroz
• Burkitt lymphoma1 toboroz
• Cerebral palsy1 toboroz
• Glioblasztóma1 toboroz
• Hearing loss1 toboroz
• Hodgkin-limfóma1 toboroz
• Hólyagrák1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Krónikus vesebetegség1 toboroz
• Magas vérnyomás1 toboroz
• Neuroendokrin daganatok1 toboroz
• Neurofibromatosis type 11 toboroz
• Peripheral artery disease1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Stroke (szélütés)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Toboroz

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07214779· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Evaluating Procedures for a Study of the AYA Survivors Coping and Emotional Needs Toolkit

  NCT06420193· East Carolina University· Forrás

• Lezárult

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· 2. fázis· Duke University· Forrás

• Visszavonták

  The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

  NCT06291415· 1. fázis· Hutchmed· Forrás

• Lezárult

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· 3. fázis· Sanofi· Forrás

• Leállították

  A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

  NCT06032546· 2. fázis· AbbVie· Forrás

• Lezárult

  Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

  NCT05776225· United Therapeutics· Forrás

• Lezárult

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· 2. fázis· Kanecia Obie Zimmerman· Forrás

• Leállították

  AB1 in Adult Patients With Sickle Cell Disease (SCD)

  NCT05261711· 1/2. fázis· Nirmish Shah· Forrás

• Lezárult

  Effects of Remote Ischemic Conditioning on Bimanual Skill Learning and Corticospinal Excitability in Children With Unilateral Cerebral Palsy

  NCT05777070· East Carolina University· Forrás

• Lezárult

  Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

  NCT05405114· 2. fázis· Novo Nordisk A/S· Forrás

• Leállították

  Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

  NCT05267106· 2. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

  NCT04987489· 2. fázis· Forma Therapeutics, Inc.· Forrás

• Lezárult

  A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

  NCT05075824· 2. fázis· Hoffmann-La Roche· Forrás

• Leállították

  Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

  NCT04930445· Pfizer· Forrás

• Leállították

  Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  NCT05070845· 2. fázis· Pfizer· Forrás

• Lezárult

  Remote Ischemic Conditioning, Bimanual Skill Learning, and Corticospinal Excitability

  NCT05355883· East Carolina University· Forrás

• Leállították

  NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC

  NCT04984811· 2. fázis· NeoImmuneTech· Forrás

• Toboroz

  Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  NCT04657822· 4. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

  NCT04825834· Delfi Diagnostics Inc.· Forrás

• Lezárult

  Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

  NCT04064242· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

  NCT04419168· University of Pittsburgh· Forrás

• Lezárult

  Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

  NCT04084080· 3. fázis· University of Pittsburgh· Forrás

• Lezárult

  Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

  NCT03836209· 2. fázis· PrECOG, LLC.· Forrás

• Leállították

  Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

  NCT03926624· 3. fázis· Delta-Fly Pharma, Inc.· Forrás

• Lezárult

  Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

  NCT04166058· 3. fázis· AbbVie· Forrás

• Lezárult

  Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

  NCT04026113· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· 3. fázis· United Therapeutics· Forrás

• Lezárult

  Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

  NCT03474965· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

  NCT03548779· University of North Carolina, Chapel Hill· Forrás

• Lezárult

  Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  NCT03092674· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

  NCT03223753· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

  NCT02932410· 3. fázis· Actelion· Forrás

• Lezárult

  Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

  NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás

• Leállították

  Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

  NCT02859896· 3. fázis· Sanofi· Forrás

• Lezárult

  Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

  NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

  NCT01793233· Children's Oncology Group· Forrás

• Lezárult

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

  NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

  NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

  NCT01454297· Multiple Myeloma Research Foundation· Forrás

• Lezárult

  Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

  NCT01190930· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

  NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

  NCT00557193· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

  NCT00379340· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

  NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

  NCT00352534· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

  NCT00107198· 2. fázis· Children's Oncology Group· Forrás

• Lezárult

  Study of Kidney Tumors in Younger Patients

  NCT00898365· Children's Oncology Group· Forrás

Showing 50 of 53.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Sarcoidosis16 munka · 1 vizsgálat
• Lyme disease4 munka · 0 vizsgálat